Antibacterial activity of reduced graphene oxide prepared by microbe
Date
2023
Authors
Zhou, Y.
Xue, C.
Gan, L.
Owens, G.
Chen, Z.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Materials Today Sustainability, 2023; 22(100341)
Statement of Responsibility
Conference Name
Abstract
In previous work, we successfully bioreduced graphene oxide (B-rGO) utilizing organisms, but the antibacterial properties of B-rGO are still unknown. In this study, Escherichia coli (E. coli) was used as a test target and the antibacterial activity of B-rGO was compared to that of commercial reduced graphene oxide (C-rGO), in order to understand its toxicity. Data from levels of extracellular lactate dehydrogenase (LDH), and intracellular reactive oxygen species (ROS) content demonstrate that cell membrane stress and oxidative stress play a role in this antibacterial process. However, when the concentration of co-existing B-rGO was 50.0 mg/L, E. coli damaged easily, the LDH release concentration was 98.75 U/L, the ROS fluorescence signal was 57.75/106 cells, and the phenomenon known as ‘wrapping’ occurred. Indicated here is that B-rGO does indeed demonstrate very good antibacterial activity as evidenced when using Scanning Electron Microscopy (SEM).
Meanwhile, numerous oxygen-containing functional groups existed on the surface of B-rGO as confirmed by Fourier transform infrared spectroscopy (FTIR). The power-time curve of microcalorimetry and flow cytometry analysis confirmed that the antibacterial activity of B-rGO was inadequate when compared to that of C-rGO. Despite E. coli mortality being dosage-dependent for both B-rGO and C-rGO, this implies that B-rGO does in fact achieve good biocompatibility. The outcomes reveal that B-rGO has great potential for environmental remediation.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
Copyright 2023 Elsevier Ltd. All rights reserved